|
|
|
貝萊德世界健康科學基金A2
(歐元)
| 幣別 |
淨值 |
漲跌 |
漲跌比例 |
日期 |
| 歐元 |
47.81 |
0.07 |
0.15% |
2020/07/09 |
|
|
| 2010 |
2011 |
2012 |
2013 |
2014 |
2015 |
2016 |
2017 |
2018 |
2019 |
| 9.02% |
8.89% |
14.80% |
37.28% |
41.27% |
16.53% |
-5.12% |
7.12% |
10.13% |
26.72% |
| 貝萊德世界健康科學基金A2(歐元)
基金資料
|
|
●以盡量提高總回報為目標。基金在全球將總資產至少70%投資於從事保健、製藥、 醫學科技及生物科技供應及開發業務公司之股權證券。
●投資經驗豐富的研究團隊。健康醫療研究團隊成立超過半世紀，擁有產業豐富的投資經驗與優異的投資績效。
●掌握健康醫療產業長期投資利機點--全球人口老化、 重大醫學科技突破，以及中國、印度、東歐等快速成長新興市場生活水準提高。
●同時囊括醫療產業中生技、製藥、醫療保險服務與設備4大領域，兼顧防禦與成長。
|
| 日期 |
淨值 |
漲跌比例 |
日期 |
淨值 |
漲跌比例 |
| 2020/07/09 |
47.81 |
0.15% |
2020/06/25 |
46.43 |
-1.07% |
| 2020/07/08 |
47.74 |
-0.17% |
2020/06/24 |
46.93 |
-0.51% |
| 2020/07/07 |
47.82 |
-0.10% |
2020/06/22 |
47.17 |
-0.59% |
| 2020/07/06 |
47.87 |
0.17% |
2020/06/19 |
47.45 |
1.17% |
| 2020/07/03 |
47.79 |
-0.04% |
2020/06/18 |
46.90 |
-0.51% |
| 2020/07/02 |
47.81 |
1.29% |
2020/06/17 |
47.14 |
1.25% |
| 2020/07/01 |
47.20 |
1.22% |
2020/06/16 |
46.56 |
3.63% |
| 2020/06/30 |
46.63 |
0.54% |
2020/06/15 |
44.93 |
-1.86% |
| 2020/06/29 |
46.38 |
-1.49% |
2020/06/12 |
45.78 |
-0.74% |
| 2020/06/26 |
47.08 |
1.40% |
2020/06/11 |
46.12 |
-1.73% |
基金績效 (可點按欄位名稱排序)
| 名稱 |
一日 |
一週 |
一個月 |
三個月 |
六個月 |
一年 |
今年以來 |
|
0.15% |
0.00% |
1.59% |
8.07% |
1.92% |
16.10% |
3.93% |
| NBI生技指數 |
-0.08% |
1.61% |
6.01% |
23.52% |
16.33% |
29.31% |
16.74% |
| 費城藥物指數 |
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
| AMEX生技指數 |
-0.14% |
2.15% |
5.72% |
25.59% |
15.62% |
24.94% |
17.33% |
| MSCI 全球醫療保健指數 (price) |
0.00% |
0.28% |
0.36% |
10.55% |
2.21% |
14.53% |
2.91% |
| MSCI 製藥指數 (price) |
0.00% |
0.05% |
-1.13% |
6.64% |
-0.99% |
8.96% |
-0.93% |
| MSCI 生物科技指數 (price) |
0.00% |
0.61% |
5.82% |
16.23% |
14.70% |
36.73% |
16.38% |
|
-0.46% |
-0.45% |
0.34% |
12.28% |
4.99% |
16.23% |
5.83% |
|
-0.46% |
-0.46% |
0.29% |
12.02% |
4.47% |
15.07% |
5.29% |
|
0.12% |
2.23% |
5.25% |
18.99% |
15.59% |
32.27% |
15.81% |
|
0.60% |
2.34% |
3.56% |
18.48% |
9.45% |
16.46% |
9.42% |
|
0.15% |
0.48% |
1.40% |
11.99% |
3.93% |
17.36% |
4.94% |
|
-0.70% |
-0.13% |
1.68% |
13.85% |
6.88% |
19.60% |
8.01% |
|
0.56% |
2.05% |
3.23% |
15.73% |
8.76% |
11.40% |
8.96% |
|
0.49% |
2.06% |
3.94% |
17.94% |
10.53% |
17.43% |
10.83% |
|
1.14% |
8.98% |
19.50% |
38.21% |
17.29% |
50.93% |
14.20% |
|
-0.57% |
-2.14% |
-1.09% |
4.13% |
-4.54% |
7.50% |
-2.12% |
|
-0.51% |
1.92% |
6.70% |
25.71% |
13.73% |
26.25% |
15.75% |
|
-0.50% |
1.90% |
6.58% |
25.32% |
12.99% |
24.58% |
14.96% |
|
0.63% |
1.22% |
-0.58% |
11.99% |
-1.90% |
11.91% |
-1.54% |
|
-0.73% |
0.15% |
3.23% |
16.04% |
5.03% |
16.70% |
5.57% |
|
-0.72% |
0.15% |
3.16% |
15.76% |
4.52% |
15.56% |
5.02% |
|
-0.73% |
0.08% |
3.06% |
15.67% |
3.79% |
13.63% |
4.26% |
|
-0.72% |
0.11% |
3.16% |
15.90% |
4.20% |
14.50% |
4.69% |
|
-0.72% |
0.16% |
3.30% |
16.28% |
5.43% |
17.57% |
5.98% |
|
0.20% |
2.25% |
4.23% |
14.57% |
13.05% |
20.51% |
12.98% |
|
0.28% |
2.44% |
7.14% |
23.48% |
15.89% |
26.33% |
17.06% |
|
0.30% |
1.98% |
7.48% |
19.59% |
14.89% |
28.19% |
17.27% |
|
0.29% |
2.47% |
7.27% |
23.94% |
17.15% |
29.56% |
18.39% |
|
0.20% |
0.74% |
1.13% |
14.84% |
-0.26% |
6.64% |
0.04% |
|
0.21% |
0.28% |
1.45% |
11.20% |
-1.11% |
8.24% |
0.24% |
|
0.21% |
0.76% |
1.25% |
15.25% |
0.85% |
9.41% |
1.20% |
|
0.44% |
3.07% |
8.86% |
29.69% |
20.59% |
37.10% |
20.71% |
|
0.13% |
1.54% |
1.39% |
13.94% |
2.38% |
14.69% |
2.61% |
|
0.49% |
1.67% |
2.01% |
14.66% |
10.11% |
25.51% |
10.71% |
|
0.46% |
1.62% |
1.86% |
17.43% |
6.83% |
22.69% |
6.83% |
| 基金平均績效 |
0.01% |
1.32% |
3.75% |
17.10% |
7.58% |
19.66% |
8.26% |
* 基金報酬率包含配息
(若未註明"*"，則基金報酬率不包含配息，對於有配息之基金，將造成總報酬率數值低估。)
本資訊僅供參考，實際數據以官方公佈資料為準。 本站自當盡力為使用者提供正確的意見及消息，但如有錯漏或疏忽，本站恕不負任何法律責任。
|
